The biofilms treatment market is segmented into surgical and traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns and other open wounds. The surgical and traumatic wounds segment accounted for the largest market share in 2019. The large share of this segment can be attributed to the growing prevalence of diabetes and the increasing number of surgical procedures performed. 

 

The biofilms treatment market is segmented into debridement equipment; gauzes and dressings; gels, ointments, and sprays; wipes, pads, and lavage solutions; and grafts and matrices. The gauzes and dressings segment accounted for the largest market share in 2019. The large share of this segment is attributed to the ability of antimicrobial products to remove, prevent, and manage biofilms. 

 

饾悊饾悶饾惌 饾悓饾惃饾惈饾悶 饾悎饾惂饾惉饾悽饾悹饾悺饾惌饾惉, 饾悊饾惈饾悮饾悰 饾悘饾悆饾悈 @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57398610 

 

07a3f520fd97d4ed83a3da66bdd7fea7.jpg

On the basis of region, the biofilms treatment market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA). In 2019, North America accounted for the largest share of the biofilms treatment market.

 

The large share of this market can be attributed to the increasing incidence of chronic wounds, rising healthcare expenditure, the introduction of novel and specialty biofilm management products, and the presence of major market players in this region.